Even Healthcare has raised $50 million, about ₹475 crore, in a Series B round, according to a StartupTalky funding roundup of 19 October 2026. Existing investor Khosla Ventures led the all-equity round, with Alpha Wave taking part. The company's total funding now exceeds $120 million.
What the money is for
Even will expand its hospital network in Bengaluru. It runs two hospitals and plans one more by the end of 2026 and three more by the end of FY27.
The company
Even is a Bengaluru-based managed care startup founded in 2020 by Mayank Banerjee, Matilde Giglio and Alessandro Ialongo. It combines preventive care, consultations, diagnostics, access to insurance and hospitalisation. The roundup says it has more than 2.5 lakh members across 10 cities. It also says unplanned re-admissions in its insurance programmes are below 1%; this is the company's claim and was not checked independently.
Another round the same day
The Pant Project, a premium menswear brand, raised ₹109 crore in a Series B led by Mirae Asset Venture Investments (India), with Sorin Investments, Hyperscale Ventures, B&K Securities, MGA Ventures and B2V Ventures and venture debt from Alteria Capital. It runs 25 exclusive stores and plans over 150 in the next two to three years.
What the report does not say
The roundup gives no valuation for either company.
Key numbers
- Round size: $50 million (About ₹475 crore)
- Total raised: Over $120 million (Including this round)
- Members: 2.5 lakh+ (10 cities, company figure)
- Hospitals: 2 → 6 (One by end-2026, three more by end of FY27)
What boards and CFOs should note
Three points stand out. First, the Even round is all equity and is aimed at physical hospitals, so the money goes into assets, not software. Second, membership and re-admission figures are the company's own, so investors and partners should ask for the underlying data. Third, both rounds fund physical expansion, which is also true of Boldfit's round last week.
Source: StartupTalky, 19 October 2026. This is a summary of a news report, published as general information. It is not legal, tax or investment advice.
This article is journalism and commentary. It is not a recommendation to buy or sell any security, and it is not professional advice. Read the full disclaimer.
